This review investigated the long-term benefits of epidural steroid injections for patients with low back pain. The authors concluded that a long-term benefit of epidural steroid injection for low back pain was not suggested at six months or longer. Introduction of selection bias in most of the injection studies seems apparent. This conclusion reliably reflects the evidence presented.
Authors' objectives
To investigate the long-term benefits of epidural steroid injections for patients with low back pain.
Searching
MEDLINE, EMBASE and The Cochrane Library were searched without language restrictions from 1950 to September 2011. Search strategies were presented.
Study selection
Eligible studies were randomised controlled trials with at least six months of follow-up that focused on epidural steroid injections given to patients with low back pain (including radiculopathy) regardless of pain duration. Studies had to report at least one of the outcomes of pain status, back-specific disability index or number of patients undergoing subsequent surgery. Pain and disability had to be measured at six to 12 months. Studies of patients with low back pain attributed to acute major trauma, cancer, infection, spondyloarthropathy, pregnancy and pain following back surgery were excluded. Studies with control groups using steroid injection or surgery were excluded.
Where reported, epidural injections were performed using caudal, interlaminar or transforaminal approaches. Most studies included patients with subacute or chronic pain; approximately one third of studies focused exclusively on chronic low back pain. Most studies included patients suffered from radicular pain. More than half of the included studies compared epidural steroid injections with epidural saline or local anaesthetic injection; the remaining comparisons comprised conservative treatment, epiduroscopy or interspinous ligament injection. Some trials included multiple comparisons. Two reviewers independently selected the studies for inclusion. Disagreements were resolved by discussion and consensus.
Assessment of study quality
Study quality was assessed using criteria developed by the Cochrane Back Group for randomisation, allocation concealment, blinding, similarity of baseline characteristics, use of cointerventions, compliance to allocated therapy, adequate reporting of drop-outs, loss to follow-up, non-differential timing of outcome assessment and use of intention to treat analysis.
The authors did not report how many reviewers were involved in the quality assessment of studies.
Data extraction
Data were extracted (or calculated/standardised, where necessary) in relation to pain scores measured on a visual analogue scale and on back-specific disability using the Oswestry Disability Index or the Roland-Morris Disability Questionnaire at six and 12 month follow-up points. Where only graphs were reported, mean scores and standard deviations were estimated, where possible. Intention-to-treat data were collected for the analysis.
Data were extracted by one reviewer and checked by a second reviewer. Differences were resolved by discussion.
Methods of synthesis
A random-effects meta-analysis was used to calculate pooled effects and 95% confidence intervals using weighted mean difference for pain, standardised mean difference for disability and relative risk in relation to subsequent surgery.
